G. Carcelain

G. Carcelain, J. Savatovsky, H. Adle-Biassette, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Specific CD8+ T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation

G. Carcelain, B. Autran, V. Leblond, 2008, Journal of Virology.

Expansion of Human Cytomegalovirus (HCMV) Immediate-Early 1-Speciﬁc CD8 (cid:1) T Cells and Control of HCMV Replication after Allogeneic Stem Cell Transplantation (cid:1)

G. Carcelain, B. Autran, V. Leblond, 2008 .

iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease.

É. Oksenhendler, G. Carcelain, B. Autran, 2017, Blood.

Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation

G. Carcelain, A. Samri, B. Autran, 2017, The Journal of infectious diseases.

Interferon-γ Release Assay vs. Tuberculin Skin Test for Tuberculosis Screening in Exposed Healthcare Workers: A Longitudinal Multicenter Comparative Study

F. Tubach, G. Carcelain, J. Lucet, 2015, Infection Control & Hospital Epidemiology.

Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease.

V. Calvez, G. Carcelain, N. Dupin, 2007, The Journal of infectious diseases.

The spectrum of malignancies in HIV‐infected patients in 2006 in France: The ONCOVIH study

É. Oksenhendler, G. Carcelain, H. Agut, 2011, International journal of cancer.

Evidence for naive T-cell repopulation despite thymus irradiation after autologous transplantation in adults with multiple myeloma: role of ex vivo CD34+ selection and age.

G. Carcelain, B. Autran, P. Debré, 2003, Blood.

Direct Quantiﬁcation of Cell-Associated HIV DNA in Isolated Rectal and Blood Memory CD4 T Cells Revealed Their Similar and Low Infection Levels in Long-Term Treated HIV-Infected Patients

G. Carcelain, R. Tubiana, A. Samri, 2018 .

Direct Quantification of Cell-Associated HIV DNA in Isolated Rectal and Blood Memory CD4 T Cells Revealed Their Similar and Low Infection Levels in Long-Term Treated HIV-Infected Patients

G. Carcelain, R. Tubiana, A. Samri, 2013, Journal of acquired immune deficiency syndromes.

Management of Multidrug-Resistant CMV Infection in Immunocompromised Patients: Case Report of a Heart-Transplant Recipient and Review of the Literature

G. Carcelain, H. Agut, B. Autran, 2015, Antiviral therapy.

Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells.

É. Oksenhendler, G. Carcelain, B. Autran, 2008, Blood.

Immune reconstitution after highly active anti-retroviral treatment of HIV infection.

G. Carcelain, B. Autran, P. Debré, 2001, Advances in experimental medicine and biology.

Recalcitrant pseudotumoral anogenital herpes simplex virus type 2 in HIV-infected patients: evidence for predominant B-lymphoplasmocytic infiltration and immunomodulators as effective therapeutic strategy.

J. Cayuela, G. Carcelain, E. Sbidian, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Idiopathic CD4 Lymphocytopenia

É. Oksenhendler, G. Carcelain, B. Autran, 2014, Medicine.

Idiopathic CD4 Lymphocytopenia

É. Oksenhendler, G. Carcelain, B. Autran, 2014, Medicine.

G. Carcelain, N. Dupin, F. Rozenberg, 2009, Archives of dermatology.

[Non-AIDS-defining malignancies in HIV patients: clinical features and perspectives].

G. Carcelain, C. Katlama, D. Costagliola, 2006, Bulletin du cancer.

T cell changes after combined nucleoside analogue therapy in HIV primary infection.

G. Carcelain, B. Autran, P. Debré, 1999, AIDS.

Therapeutic Vaccines for Chronic Infections

G. Carcelain, B. Autran, P. Debré, 2004, Science.

Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen.

V. Calvez, G. Carcelain, R. Tubiana, 1999, AIDS.

Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus.

G. Carcelain, B. Autran, A. Guihot, 2011, Trends in immunology.

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy

C. Tural, G. Carcelain, R. Tubiana, 2001, AIDS.

Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.

O. Traoré, V. Calvez, G. Carcelain, 2008, The Journal of antimicrobial chemotherapy.

L. Quéro, G. Carcelain, C. Katlama, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.

É. Oksenhendler, G. Carcelain, B. Autran, 2006, The Journal of infectious diseases.

Comparison of three immunoassays for infliximab trough level monitoring in paediatric inflammatory bowel diseases.

J. Hugot, G. Carcelain, V. Guérin-El Khourouj, 2021, Biologicals : journal of the International Association of Biological Standardization.

Immune interventions in HIV infection

G. Carcelain, B. Autran, 2013, Immunological reviews.

IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia

Brigitte Autran, Roland Tubiana, Christine Katlama, 2003, AIDS.

CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3

G. Carcelain, Y. Yazdanpanah, M. Guiguet, 2008, Antiviral therapy.

Very early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and Δ32 heterozygote HIV-1-infected patient was not associated with functional cure.

G. Carcelain, R. Tubiana, C. Katlama, 2015, The Journal of antimicrobial chemotherapy.

Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.

G. Carcelain, A. Samri, B. Autran, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir

V. Calvez, G. Carcelain, R. Tubiana, 2016, AIDS.

Immune Reconstitution of the CD4 T‐Cell Compartment in HIV Infection

G. Carcelain, B. Autran, P. Debré, 2001 .

A systematic comparison of methods to measure HIV-1 specific CD8 T cells.

G. Carcelain, A. Samri, B. Autran, 2003, Journal of immunological methods.

Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-γ–producing T Cell Memory to Smallpox in Humans

G. Carcelain, A. Samri, B. Autran, 2004, The Journal of experimental medicine.

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy.

G. Carcelain, B. Autran, P. Debré, 2001, Current opinion in immunology.

Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy.

V. Calvez, G. Carcelain, R. Tubiana, 2014, The Journal of antimicrobial chemotherapy.

Increased surface receptor Fas (CD95) levels on CD4+ lymphocytes in patients with primary intestinal lymphangiectasia

G. Carcelain, S. Vignes, 2009, Scandinavian journal of gastroenterology.

CD4+Ki67+ lymphocytes in HIV‐infected patients are effector T cells accumulated in the G1 phase of the cell cycle

V. Calvez, G. Carcelain, R. Tubiana, 2000, European journal of immunology.

PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study.

G. Carcelain, C. Lebbé, L. Biard, 2022, The Lancet. Oncology.

Genetic Diversity and Drug Resistance Mutations in HIV type 1 from Untreated Patients in Bamako, Mali

O. Traoré, V. Calvez, G. Carcelain, 2007, Antiviral therapy.

T-cell receptor repertoire in neuroblastoma patients.

G. Carcelain, B. Escudier, T. Hercend, 1996, Cancer research.

What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM

P. André, G. Carcelain, A. Samri, 2017, EBioMedicine.

T Cells δγ and KIR-Negative Involves Tuberculin-Specific CD 4 Th 1 Cells Syndrome in HIV-1-Infected Patients Tuberculosis-Associated Immune Restoration Autran

E. Vicaut, G. Carcelain, A. Samri, 2009 .

Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

G. Carcelain, C. Katlama, B. Autran, 2005, The Journal of experimental medicine.

Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies

G. Carcelain, X. Mariette, S. Pavy, 2009, Arthritis research & therapy.

Evidence for in situ amplification of tumor-specific cytotoxic T lymphocytes in a human regressive melanoma

G. Carcelain, A. Mackensen, L. Ferradini, 1993 .

T Cells Subtypes in a Patient With Interferon-&agr; Induced Sarcoidosis

G. Carcelain, B. Autran, J. Monsuez, 2009, The American journal of the medical sciences.

CD34+ selection and age autologous transplantation in adults with multiple myeloma: role of ex-vivo Evidence for naive T-cell repopulation despite thymus irradiation after

G. Carcelain, B. Autran, P. Debré, 2013 .

A Treatment-Decision Score for HIV-Infected Children With Suspected Tuberculosis

C. Delacourt, G. Carcelain, S. Godreuil, 2019, Pediatrics.

Four days a week or less on appropriate anti‐HIV drug combinations provided long‐term optimal maintenance in 94 patients: the ICCARRE project

G. Carcelain, J. Izopet, J. Melchior, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Increase of HIV-1 Pro-Viral Dna per Million Peripheral Blood Mononuclear Cells in Patients with Advanced HIV Disease (Cd4<200 Cells/Mm3) Receiving Interleukin 2 Combined with Haart Versus Haart Alone (Anrs-082 Trial)

M. Mouroux, V. Calvez, G. Carcelain, 2002, Antiviral therapy.

Castleman disease in HIV-infected patients interleukin-10 , and C reactive protein correlate with exacerbation of High levels of human herpesvirus 8 viral load , human interleukin

É. Oksenhendler, G. Carcelain, F. Agbalika, 2000 .

Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

G. Carcelain, Z. Amoura, B. Bader-Meunier, 2020, Annals of the Rheumatic Diseases.

Tuberculosis-Associated Immune Restoration Syndrome in HIV-1-Infected Patients Involves Tuberculin-Specific CD4 Th1 Cells and KIR-Negative γδ T Cells1

E. Vicaut, G. Carcelain, A. Samri, 2009, The Journal of Immunology.

Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study.

G. Carcelain, C. Delaugerre, J. Laplanche, 2020, The Journal of antimicrobial chemotherapy.

Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094).

V. Calvez, G. Carcelain, R. Tubiana, 2005, Vaccine.

Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study – ANRS 082

V. Calvez, G. Carcelain, R. Tubiana, 2002, AIDS.

Human immunodeficiency virus-associated polymyositis during immune restoration with combination antiretroviral therapy.

G. Carcelain, D. Vittecoq, P. Sellier, 2000, The American journal of medicine.

Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients

C. Charpentier, G. Carcelain, C. Delaugerre, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.

M. Mouroux, V. Calvez, G. Carcelain, 2001, AIDS.

[Antiretroviral therapy and immune reconstitution].

V. Calvez, G. Carcelain, R. Tubiana, 1999, Journal de la Societe de biologie.

Plasticity of lymphoid compartments during HIV infection and treatments: hopes and limits.

G. Carcelain, B. Autran, P. Debré, 2002, Microbes and infection.

Characteristics of circulating KSHV-infected viroblasts during active KSHV+ multicentric Castleman disease

É. Oksenhendler, G. Carcelain, C. Lebbé, 2022, Blood advances.

Proliferative, IFNγ and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection

F. Brun-Vézinet, G. Carcelain, B. Autran, 2006, AIDS.

Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.

G. Carcelain, H. Agut, B. Autran, 2014, American journal of respiratory and critical care medicine.

T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals

G. Carcelain, B. Autran, T. Ottenhoff, 2007, BMC infectious diseases.

Changing Electrolyte and Acido-Basic Profile in HIV-Infected Patients in the HAART Era

S. Tezenas du Montcel, G. Carcelain, C. Katlama, 2006, Nephron Physiology.

Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery.

G. Carcelain, R. Tubiana, C. Katlama, 2003, Clinical Infectious Diseases.

Fetal death as a result of placental immune reconstitution inflammatory syndrome.

G. Carcelain, R. Tubiana, C. Katlama, 2010, The Journal of infection.

Optimizing COVID-19 Vaccination Strategy in Pediatric Kidney Transplant Recipients: Humoral and Cellular Response to SARS-CoV-2 mRNA Vaccination

G. Carcelain, C. Delaugerre, J. Hogan, 2023, Transplant International.

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm3 at the time of diagnosis according to HIV‐1 coreceptor tropism

V. Calvez, C. Charpentier, G. Carcelain, 2012, Journal of Medical Virology.

HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis.

G. Carcelain, C. Katlama, B. Autran, 2011, Blood.

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy

V. Calvez, G. Carcelain, R. Tubiana, 2010, AIDS.